2001
DOI: 10.1016/s0006-8993(00)03101-2
|View full text |Cite
|
Sign up to set email alerts
|

Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 21 publications
0
9
0
Order By: Relevance
“…Though dantrolene is most commonly used clinically to treat spasticity, the drug's ability to stabilize abnormal neuronal calcium handling (Chen et al, 2008; Liu et al, 2009; Nagatomo et al, 2001) and to prevent attacks in tottering mice and seizures in other mice (Nagatomo et al, 2001; Swiader et al, 2002) suggests that it could be used similarly to block episodic neuronal dysfunction in patients. Indeed, compounds that regulate calcium signaling, particularly verapamil which is an L-type calcium channel blocker, have been used as treatments for hemiplegic migraine, severe myoclonic epilepsy of infancy and paroxysmal dyskinesia (Hsu et al, 2008; Iannetti et al, 2009; Links et al, 1998; Szczaluba et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Though dantrolene is most commonly used clinically to treat spasticity, the drug's ability to stabilize abnormal neuronal calcium handling (Chen et al, 2008; Liu et al, 2009; Nagatomo et al, 2001) and to prevent attacks in tottering mice and seizures in other mice (Nagatomo et al, 2001; Swiader et al, 2002) suggests that it could be used similarly to block episodic neuronal dysfunction in patients. Indeed, compounds that regulate calcium signaling, particularly verapamil which is an L-type calcium channel blocker, have been used as treatments for hemiplegic migraine, severe myoclonic epilepsy of infancy and paroxysmal dyskinesia (Hsu et al, 2008; Iannetti et al, 2009; Links et al, 1998; Szczaluba et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…It has been documented that dantrolene suppressed convulsive seizures in EL mice (Nagatomo et al 2001). Dantrolene at very large doses (from 62.5 to 500 mg/kg, i.p.)…”
Section: Effects Of Dantrolene On Seizures In Kindled Ratsmentioning
confidence: 99%
“…Recent studies have shown that generalized convulsions are an epiphenomenon of NMDA and PKC activation, and NO production (20–22). It is still unknown why these neurochemical processes sometimes result in seizures (first group) and other times do not (second group).…”
Section: Discussionmentioning
confidence: 99%